2020
DOI: 10.1016/j.prnil.2019.09.004
|View full text |Cite
|
Sign up to set email alerts
|

Laparoscopic radical prostatectomy versus robot-assisted radical prostatectomy: comparison of oncological outcomes at a single center

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 32 publications
1
7
0
Order By: Relevance
“…LRP has rapidly emerged as an alternative to open RP, with the advantage of reducing blood loss and length of hospital stay ( 1 , 11 ). Subsequently, with the superiority of robotic surgical platforms in providing a three-dimensional magnified visualization of the surgical field, improved dexterity, and high precision, RARP is generally considered an excellent evolution of minimally invasive surgery to address the difficulties inherent in complex laparoscopic surgery ( 12 ) and has been widely adopted for localized PCa since 2001 ( 13 15 ). However, given the prohibitively high cost of robotic systems and the scarcity of scientific evidence supporting the benefits of RARP over LRP, LRP is still routinely performed for localized PCa in many centers across Europe and Asia ( 16 , 17 ).…”
Section: Introductionmentioning
confidence: 99%
“…LRP has rapidly emerged as an alternative to open RP, with the advantage of reducing blood loss and length of hospital stay ( 1 , 11 ). Subsequently, with the superiority of robotic surgical platforms in providing a three-dimensional magnified visualization of the surgical field, improved dexterity, and high precision, RARP is generally considered an excellent evolution of minimally invasive surgery to address the difficulties inherent in complex laparoscopic surgery ( 12 ) and has been widely adopted for localized PCa since 2001 ( 13 15 ). However, given the prohibitively high cost of robotic systems and the scarcity of scientific evidence supporting the benefits of RARP over LRP, LRP is still routinely performed for localized PCa in many centers across Europe and Asia ( 16 , 17 ).…”
Section: Introductionmentioning
confidence: 99%
“…With the superiority of surgical robots in a three-dimensional magnified vision of the surgical field, improved dexterity, and high precision during the surgical procedure, robot-assisted RP (RARP) is considered a great evolution of minimally invasive surgery to reduce the difficulty associated with complex laparoscopic surgery [ 12 ], and it has been widely disseminated for localized PCa since 2001 [ 13 ]. However, given the prohibitively high cost of robotic systems and the scarcity of scientific evidence supporting RARP over laparoscopic RP (LRP), the latter was still routinely performed for localized PCa at many centers in Europe and Asia [ 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, given the prohibitively high cost of robotic systems and the scarcity of scientific evidence supporting RARP over laparoscopic RP (LRP), the latter was still routinely performed for localized PCa at many centers in Europe and Asia [ 14 , 15 ]. Furthermore, thus far, whether the advantage of RARP over LRP mentioned above could translate into superior functional preservation and oncological control remains inconclusive due to the scarcity of high-level evidence comparing RARP and LRP for localized PCa [ 12 , 16 ]. Only three randomized controlled trials concentrated on comparing RARP and LRP for localized PCa, with different endpoints over short-term study periods [ 17 19 ], which is far from reaching a convincing consensus about the controversy.…”
Section: Introductionmentioning
confidence: 99%
“…However, thus far, whether the advantages of RARP over laparoscopic RP (LRP) mentioned above could translate into superior functional preservation and oncological control was still inconclusive due to the scarcity of high-level evidence comparing RARP and LRP for localized PCa (10,12). There are only three randomized controlled trials (RCTs) concentrating on comparing RARP and LRP for localized PCa with different endpoints over the short-term study periods (13)(14)(15), which is far from reaching a convincing consensus about the controversy.…”
Section: Introductionmentioning
confidence: 99%